Evidence map›Paper›PMID 26568852›Full record

ArticleIranian Red Crescent medical journal2015

Status of p53 and p27(KIP1) in Iranian Patients With Oral Squamous Cell Carcinoma.

Shahroo Etemad-Moghadam, Amanollah Keyhani, Kamran Yazdani, Mojgan Alaeddini

Open access · bronzeAbstract read
In one paragraph

Article in Iranian Red Crescent medical journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shahroo Etemad-MoghadamDental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, IR Iran.
Amanollah KeyhaniMeraj Cancer Institute, Tehran University of Medical Sciences, Tehran, IR Iran.
Kamran YazdaniDepartment of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran.
Mojgan AlaeddiniDental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, IR Iran.
Tehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlterations in p53 and p27(KIP1) have been documented as important events in the carcinogenesis of various cancers, but their prognostic role in oral squamous cell carcinoma (OSCC) remains controversial.

objectivesThe present investigation aimed to evaluate the clinicopathologic and prognostic significance of p53 and p27(KIP1) expression in a group of Iranian patients with OSCC. PATIENTS AND

methodsIn this analytical cross-sectional study, medical records of patients with primary OSCC, diagnosed from 1994 to 2004 were reviewed and 28 subjects were selected based on the inclusion/exclusion criteria. Immunohistochemical staining using monoclonal antibodies against p53 and p27(KIP1) was performed on representative archival paraffin blocks. Demographic data along with information on p53 and p27(KIP1) expression, recurrence, and tumor grade was statistically analyzed using the Fischer exact test. Prognostic factors for overall survival were determined by Cox regression analysis (P < 0.05).

resultsp53 and p27(KIP1) expression were found in 28.57% (8 positive versus 20 negative) and 67.85% (19 positive versus 9 negative) of OSCC cases, respectively. There was no significant association between these two proteins (P = 0.371), and neither of them showed a significant relationship with the studied clinicopathologic variables (P > 0.05). In survival analysis, only histopathologic differentiation (17 low and moderate, 11 poor) demonstrated a significant correlation with overall survival (P = 0.048).

conclusionsDespite the fact that abnormalities in p53 and p27(KIP1) may be involved in the development of OSCC, their clinical significance in the studied population seems limited. Further investigation on the combined p53/p27(KIP1) expression may be helpful in predicting the biologic behavior of this tumor.

Indexed as

Cyclin-Dependent Kinase Inhibitor p27Squamous Cell CarcinomaSurvivalTumor Suppressor Protein p53

Identifiers

PMID26568852
PMCPMC4640065
OpenAlexW2184916838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.